MedTrace Logo

The Clinical Efficacy And Safety Of SkinStylus Microneedling System

NCT03366194 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2022-05-11

Study results available
· View outcomes & findings →

Summary

The purpose of the trial is to provide objective evidence the SkinStylus may be used safely and effectively for the treatment of ventral torso hypertrophic scars.

Conditions

  • Cicatrix, Hypertrophic

Interventions

DEVICE

SkinStylus Sterilock System

Microneedling device will be used to treat ventral hypertrophic scars.

Sponsors & Collaborators

  • Esthetic Education LLC

    lead INDUSTRY

Principal Investigators

  • Toni Stockton, MD · Principal Investigator for Esthetic Education LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
23 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-15
Primary Completion
2018-11-01
Completion
2018-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366194 on ClinicalTrials.gov